IBD Innovate: Product Development for Crohn’s & Colitis™

IBDInnovate

 

Virtual Conference | November 17-18, 2020 | Register today 


Join us November 17-18 for IBD INNOVATE: Product Development for Crohn’s & Colitis™! This unique event will showcase innovative product development programs in IBD and offer extensive partnering and networking opportunities.

Click here to register, and don't miss our early bird discount offered now through August 6!

About the 2020 program

IBD Innovate is designed for all stakeholders dedicated to advancing innovative products to address the critical challenges faced by IBD patients. Our 2020 program will take place on an interactive virtual conference platform, allowing for live Q&A during research talks and poster sessions. Attendees are also encouraged to take advantage of matchmaking software for 1:1 partnering, "speed dating," and other informal networking venues.

Agenda overview

Talks, posters and group networking events are scheduled for:

  • Tuesday, November 17th, 2020 | 11:00 AM - 5:00 PM EST
  • Wednesday, November 18th, 2020 | 11:00 AM - 5:00 PM EST

One-on-one partnering will be available all day on both November 17th and 18th.

Learn more about our 2020 agenda

    Keynote speaker

    ramnik-xavier-ibdinnovate

    Ramnik Xavier, MD

    Kurt Isselbacher Professor of Medicine, Harvard Medical School; Core Member, Broad Institute; Director, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital

    Ramnik Xavier will present a keynote address on novel therapeutics discovery based on emerging concepts in IBD biology. 

    Learn more about featured 2020 speakers and topics


    About the IBD Innovate conference series

    Overview

    The Crohn's & Colitis Foundation seeks to accelerate the discovery and development of novel products with the potential to address the unmet needs of patients with IBD. In pursuit of this objective, the Foundation recently launched IBD Ventures to directly fund product development, and IBD Innovate, now in its third year, to build awareness and connections across the IBD product development ecosystem.

    Our IBD Innovate series features:

    • Presentations on compelling inflammatory bowel disease (IBD) product opportunities in:
      • Therapeutics (from compound discovery through clinical development)
      • Devices
      • Diagnostics
      • Healthcare technology (software, services etc.)
    • Networking & connections between diverse stakeholders in the IBD space

    Target audience

    Startup companies, accelerator organizations (industry, non-profit & academic), industry representatives (R&D, clinical development, external R&D, scouting, partnering, business development, corporate venture), academic researchers, investors (venture capital & other), disease foundations and other non-profit funders, contract research organizations, service providers, clinicians, and patient advocates.

    Browse past programs


    Questions? Contact us

    Program-related inquiries:

    Paul Larkin – [email protected]

    Sponsorship-related inquiries:
    Nicholas Roman – (646) 943-7493 or [email protected]

    Subscribe to our email list for updates on IBD Innovate and related programs

     

      IBD Innovate is generously supported, in part, by:

      Eli Lilly and Company